Study identity card

MINIRICO

Norway
Share
  • Disease: Post-COVID-19
  • Study type: Randomised Clinical Trial
  • Study type descriptors: Interventional, Single centre
  • Study aim: To determine whether Nicotinamide Riboside and/or Mind-Body Reprocessing Therapy increase health-related quality of life in individuals with long COVID compared with care as usual and/or placebo
  • Number of participants enrolled: 310
  • Study enrolling from to
  • Study includes follow-up for 3 months

Study Data

  • General population
  • Elderly
  • Adult
  • Community
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Dietary
  • Psychotherapy

Other information

If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it

The data is updated up to